Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5,616 | 2 | 99.6% |
| Education | $19.81 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $5,636 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,616 | 2 | Merck Sharp & Dohme LLC ($5,616) |
| 2023 | $19.81 | 1 | Merck Sharp & Dohme LLC ($19.81) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | — | In-kind items and services | $3,743.84 | Research |
| Study: Phase II, multi cohort trial of neoadjuvant and post surgery IO102 IO103 and pembrolizumab in patients with selected resectable tumors • Category: ONCOLOGY | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | — | In-kind items and services | $1,871.92 | Research |
| Study: Phase II, multi cohort trial of neoadjuvant and post surgery IO102 IO103 and pembrolizumab in patients with selected resectable tumors • Category: ONCOLOGY | ||||||
| 01/11/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase II, multi cohort trial of neoadjuvant and post surgery IO102 IO103 and pembrolizumab in patients with selected resectable tumors | Merck Sharp & Dohme LLC | $5,616 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 211 | 405 | $145,709 | $38,953 |
| 2022 | 5 | 194 | 408 | $146,996 | $40,025 |
| 2021 | 5 | 157 | 265 | $96,186 | $25,897 |
| 2020 | 11 | 228 | 403 | $105,138 | $25,350 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 94 | $37,894 | $10,335 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 78 | $31,410 | $8,580 | 27.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 64 | $18,838 | $5,916 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 52 | $15,559 | $3,670 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 50 | $15,000 | $3,663 | 24.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $12,652 | $2,982 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $8,038 | $1,886 | 23.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 19 | $3,874 | $1,168 | 30.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 12 | $2,444 | $753.36 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 51 | 119 | $47,771 | $13,328 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 96 | $38,400 | $10,897 | 28.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 70 | $20,440 | $5,453 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 45 | $13,365 | $3,445 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 21 | 21 | $11,991 | $2,959 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 37 | $10,989 | $2,868 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 20 | $4,040 | $1,074 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 54 | 113 | $45,200 | $13,051 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 48 | 97 | $28,809 | $7,589 | 26.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $17,130 | $4,085 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 14 | $2,814 | $702.91 | 25.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 11 | $2,233 | $468.66 | 21.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 39 | 95 | $18,833 | $5,555 | 29.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 20 | 62 | $17,672 | $4,541 | 25.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 23 | 43 | $16,924 | $3,858 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 30 | 48 | $14,121 | $2,833 | 20.1% |
About Dr. Erin Alesi, MD
Dr. Erin Alesi, MD is a Hematology & Oncology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679779540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Alesi, MD has received a total of $5,636 in payments from pharmaceutical and medical device companies, with $5,616 received in 2024. These payments were reported across 3 transactions from 1 company. The most common payment nature is "" ($5,616).
As a Medicare-enrolled provider, Alesi has provided services to 790 Medicare beneficiaries, totaling 1,481 services with total Medicare billing of $130,225. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Richmond, VA
- Active Since 06/26/2007
- Last Updated 08/01/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1679779540
Products in Payments
- KEYTRUDA (Biological) $5,636
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Richmond
Dr. Victor Yazbeck, M.d, M.D
Hematology & Oncology — Payments: $390,374
Attique Samdani, M.d, M.D
Hematology & Oncology — Payments: $146,382
Dr. Elke Friedman, Md, MD
Hematology & Oncology — Payments: $25,274
Dr. Asit Paul, M.d., Ph.d.,, M.D., PH.D.,
Hematology & Oncology — Payments: $7,490
Dr. Ghulam Qureshi, M.d, M.D
Hematology & Oncology — Payments: $7,032
Gisa-Beate Schunn, M.d, M.D
Hematology & Oncology — Payments: $5,929